Recombinant human erythropoietin administration in cardiac surgery

Yazicioglu, L; Eryilmaz, S; Sirlak, MUSTAFA; Inan, MB; Aral, ATİLLA; Tasoz, R; Eren, NT; Kaya, B; Akalin, H

doi:10.1067/mtc.2001.115426

Recombinant human erythropoietin administration in cardiac surgery

Yazicioglu L., Eryilmaz S., Sirlak M., Inan M., Aral A., Tasoz R., ...Daha Fazla

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, cilt.122, sa.4, ss.741-745, 2001 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 122 Sayı: 4
Basım Tarihi: 2001
Doi Numarası: 10.1067/mtc.2001.115426
Dergi Adı: JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.741-745
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Ankara Üniversitesi Adresli: Evet

Özet

Objective: Postoperative anemia and multiple blood transfusions are still important problems in cardiac surgery. During the past few years, there have been some reports indicating that multiple recombinant human erythropoietin infusions starting at least 2 weeks before the operation induced erythropoiesis. We aimed to reduce the risk of adverse reactions of high doses of recombinant human erythropoietin and reduce the period of hospitalization by using it only once, 4 days before the operation.